RhumbLine Advisers’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-6,167
| Closed | -$53K | – | 4216 |
|
2025
Q1 | $53K | Sell |
6,167
-707
| -10% | -$6.08K | ﹤0.01% | 3558 |
|
2024
Q4 | $246K | Buy |
6,874
+200
| +3% | +$7.15K | ﹤0.01% | 3097 |
|
2024
Q3 | $315K | Sell |
6,674
-369
| -5% | -$17.4K | ﹤0.01% | 2996 |
|
2024
Q2 | $354K | Sell |
7,043
-115
| -2% | -$5.78K | ﹤0.01% | 2905 |
|
2024
Q1 | $802K | Buy |
7,158
+755
| +12% | +$84.6K | ﹤0.01% | 2377 |
|
2023
Q4 | $371K | Hold |
6,403
| – | – | ﹤0.01% | 2836 |
|
2023
Q3 | $203K | Sell |
6,403
-192
| -3% | -$6.1K | ﹤0.01% | 3155 |
|
2023
Q2 | $542K | Buy |
6,595
+261
| +4% | +$21.5K | ﹤0.01% | 2638 |
|
2023
Q1 | $651K | Buy |
6,334
+215
| +4% | +$22.1K | ﹤0.01% | 2313 |
|
2022
Q4 | $896K | Buy |
6,119
+211
| +4% | +$30.9K | ﹤0.01% | 2191 |
|
2022
Q3 | $998K | Buy |
5,908
+486
| +9% | +$82.1K | ﹤0.01% | 2130 |
|
2022
Q2 | $626K | Buy |
5,422
+2,227
| +70% | +$257K | ﹤0.01% | 2370 |
|
2022
Q1 | $319K | Sell |
3,195
-36
| -1% | -$3.59K | ﹤0.01% | 2622 |
|
2021
Q4 | $502K | Sell |
3,231
-79
| -2% | -$12.3K | ﹤0.01% | 2507 |
|
2021
Q3 | $780K | Buy |
3,310
+97
| +3% | +$22.9K | ﹤0.01% | 2342 |
|
2021
Q2 | $1.09M | Buy |
3,213
+498
| +18% | +$169K | ﹤0.01% | 2210 |
|
2021
Q1 | $1.1M | Sell |
2,715
-87
| -3% | -$35.2K | ﹤0.01% | 2152 |
|
2020
Q4 | $1.86M | Buy |
2,802
+215
| +8% | +$143K | ﹤0.01% | 1881 |
|
2020
Q3 | $1.2M | Sell |
2,587
-179
| -6% | -$83.3K | ﹤0.01% | 1917 |
|
2020
Q2 | $1.62M | Buy |
2,766
+638
| +30% | +$373K | ﹤0.01% | 1847 |
|
2020
Q1 | $310K | Buy |
2,128
+274
| +15% | +$39.9K | ﹤0.01% | 2389 |
|
2019
Q4 | $266K | Buy |
1,854
+98
| +6% | +$14.1K | ﹤0.01% | 2648 |
|
2019
Q3 | $69K | Buy |
1,756
+177
| +11% | +$6.96K | ﹤0.01% | 2914 |
|
2019
Q2 | $160K | Buy |
1,579
+909
| +136% | +$92.1K | ﹤0.01% | 2844 |
|
2019
Q1 | $88K | Buy |
670
+26
| +4% | +$3.42K | ﹤0.01% | 2875 |
|
2018
Q4 | $66K | Buy |
644
+204
| +46% | +$20.9K | ﹤0.01% | 2921 |
|
2018
Q3 | $110K | Sell |
440
-31
| -7% | -$7.75K | ﹤0.01% | 2852 |
|
2018
Q2 | $211K | Buy |
+471
| New | +$211K | ﹤0.01% | 2707 |
|